Shorla Oncology Competitors and Similar CompaniesClear all
Shorla Oncology's competitors and similar companies include Citius Oncology, SyzOnc and Emtora Biosciences.
 Shorla Oncology Shorla Oncology (also known as Shorla Pharma) is a pharmaceutical company that develops cancer treatment solutions. |  Citius Oncology Citius Oncology is a company that operates a platform to develop and commercialize novel targeted oncology therapies. |  Emtora Biosciences Emtora Biosciences is a life science company developing eRap, a formulation of rapamycin for the prevention of cancer progression/recurrence. | ||
Founding Date | Founding Date 2018 | Founding Date 2021 | Founding Date 2023 | Founding Date N/A |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Clonmel, IE HQ Cambridge, US | Locations New York, US HQ | Locations Philadelphia, US HQ | Locations San Antonio, US HQ |
Employees | Employees 4914% increase | Employees N/A | Employees 5 | Employees 2 |
Funding | ||||
Latest funding round | Latest funding round $ 35m (almost 3 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 3m (almost 7 years ago) |
Total funding raised | Total funding raised $ 43.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 3m |
For sources of this data, please see the company profile
View Company Profiles
Citius Oncology
HQ
New York, US
Citius Oncology is a company that operates a platform to develop and commercialize novel targeted oncology therapies.
View company
SyzOnc
HQ
Philadelphia, US
Employees
5
SyzOnc is a company that develops immunotherapy solutions.
View companyEmtora Biosciences
HQ
San Antonio, US
Employees
2
Emtora Biosciences is a life science company developing eRap, a formulation of rapamycin for the prevention of cancer progression/recurrence.
View company